Health Sciences North
6
2
2
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 6 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
SWiFT Canada (Study of Whole Blood in Frontline Trauma)
Role: collaborator
Assessment of Quality of Life and Outcomes in Patients With Primary Renal Cell Carcinoma Treated With SBRT
Role: collaborator
Early Psychosis Intervention - Spreading Evidence-based Treatment
Role: collaborator
Evaluation of Nurse-led Integrated Care of Complex Patients Facilitated By Telemonitoring: The SMaRT Study
Role: collaborator
Neurorehabilitation of the Hand
Role: collaborator
Optimal Training Frequency for Attainment and Maintenance of High-quality CPR on a High-fidelity Manikin
Role: lead
All 6 trials loaded